Kiniksa Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
– ARCALYST® (rilonacept) net revenue of $27.0 million in Q2 2022 – – ARCALYST full-year…
Month: August 2022
AEON Biopharma Raises $30 Million from Insiders
Brings Total Capital Raised Since December 2021 to $54.5 Million IRVINE, Calif., Aug. 03, 2022…
MediWound Announces U.S. FDA Acceptance of Biologics License Application for NexoBrid for the Treatment of Severe Thermal Burns
Prescription Drug User Fee Act (PDUFA) target date of January 1, 2023 YAVNE, Israel, Aug….
Kiniksa Pharmaceuticals Announces Global License Agreement with Genentech for Vixarelimab
– Kiniksa to receive $100 million in upfront and near-term payments – – Kiniksa is…
U.S. Patent Issued to HCW Biologics for Foundational Platform Technology
Issued Claims for Single-Chain Chimeric Polypeptide and Composition Claims for Lead Product Candidate, HCW9302 MIRAMAR, Fla.,…
Clearside Biomedical to Participate in Three Upcoming Investor Conferences in August 2022
ALPHARETTA, Ga., Aug. 03, 2022 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing…
Tilray Wellness Announces U.S. Distribution Agreement with Southern Glazer’s Wine & Spirits for CBD Beverages
NEW YORK, Aug. 03, 2022 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”)…
Roivant Sciences to Report Financial Results for the Quarter Ended June 30, 2022 on Monday, August 15, 2022
Investor call and webcast scheduled for Monday, August 15 at 8:00 a.m. EDT Roivant will…
EyePoint Pharmaceuticals Reports Second Quarter 2022 Financial Results and Highlights Recent Corporate Developments
– First patient dosed in the Phase 2 DAVIO 2 clinical trial for wet age-related macular…
Surface Oncology Reports Financial Results and Business Highlights for Second Quarter 2022
– SRF388 clinical data presented at 2022 ASCO Annual Meeting demonstrated monotherapy responses in two…
Zentalis Pharmaceuticals to Participate in the Wedbush PacGrow Healthcare Conference
NEW YORK and SAN DIEGO, Aug. 03, 2022 (GLOBE NEWSWIRE) — Zentalis Pharmaceuticals, Inc. (Nasdaq:…
ADMA Biologics to Report Second Quarter 2022 Financial Results on August 10, 2022
Conference Call Scheduled for August 10, 2022, at 4:30 p.m. ET RAMSEY, N.J. and BOCA…
TScan Therapeutics to Participate in the 13th Annual Wedbush PacGrow Healthcare Conference
WALTHAM, Mass., Aug. 03, 2022 (GLOBE NEWSWIRE) — TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage…
Zynerba Pharmaceuticals to Present In Person at the Canaccord Genuity 42nd Annual Growth Conference
DEVON, Pa., Aug. 03, 2022 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader…
Sutro Biopharma to Present at the 2022 Wedbush PacGrow Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Aug. 03, 2022 (GLOBE NEWSWIRE) — Sutro Biopharma, Inc. (Sutro or…
BioXcel Therapeutics to Participate at the Canaccord Genuity 42nd Annual Growth Conference
NEW HAVEN, Conn., Aug. 03, 2022 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a…
Immunocore to Report Second Quarter 2022 Earnings and Host Call on August 10, 2022
Immunocore to Report Second Quarter 2022 Earnings and Host Call on August 10, 2022 (OXFORDSHIRE,…
Amarin Reports Second Quarter 2022 Financial Results and Provides Business Update
Company Received Final Positive Reimbursement Decision for VAZKEPA® by UK’s NICE in England & Wales…
Cara Therapeutics to Present at the Canaccord Genuity 42nd Annual Growth Conference
STAMFORD, Conn., Aug. 03, 2022 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical…
Bioventus Receives FDA 510(k) Clearance for SonaStar Elite
Innovative New Handpiece Addition to the Nexus Ultrasonic Generator Significantly Expands Company’s Offering in Neurosurgery…